ABSTRACT:Unbound fractions in mouse brain and plasma were determined for 31 structurally diverse central nervous system (CNS) drugs and two active metabolites. Three comparisons were made between in vitro binding and in vivo exposure data, namely: 1) mouse brainto-plasma exposure versus unbound plasma-to-unbound brain fraction ratio (fu plasma /fu brain ), 2) cerebrospinal fluid-to-brain exposure versus unbound brain fraction (fu brain ), and 3) cerebrospinal fluid-to-plasma exposure versus unbound plasma fraction (fu plasma ). Unbound fraction data were within 3-fold of in vivo exposure ratios for the majority of the drugs examined (i.e., 22 of 33), indicating a predominately free equilibrium across the blood-brain and blood-CSF barriers. Some degree of distributional impairment at either the blood-CSF or the blood-brain barrier was indicated for 8 of the 11 remaining drugs (i.e., carbamazepine, midazolam, phenytoin, sulpiride, thiopental, risperidone, 9-hydroxyrisperidone, and zolpidem). In several cases, the indicated distributional impairment is consistent with other independent literature reports for these drugs. Through the use of this approach, it appears that most CNS-active agents freely equilibrate across the blood-brain and blood-CSF barriers such that unbound drug concentrations in brain approximate those in the plasma. However, these results also support the intuitive concept that distributional impairment does not necessarily preclude CNS activity.
Beetle luciferases have been adapted for live cell imaging where bioluminescence is dependent on the cellular availability of ATP, O 2 , and added luciferin. Previous Photinus pyralis red-emitting variants with high K m values for ATP have performed disappointingly in live cells despite having much higher relative specific activities than enzymes like Click Beetle Red (CBR). We engineered a luciferase variant PLR3 having a K m value similar to CBR and ~2.6-fold higher specific activity.The red-emitting PLR3 was ~2.5-fold brighter than CBR in living HEK293T and HeLa cells, an improvement consistent with the importance of the K m value in low ATP environments. KeywordsBioluminescence; firefly; luciferase; ATP; red-emitting; imaging Bioluminescent proteins, epitomized by the beetle luciferases (Lucs), are now proven reagents for noninvasive imaging studies. As reporters, bioluminescent enzymes can visualize genetic activity and many other cellular biochemical events; while in living animals, they can be used to track specific types of cells including tumors [1][2][3][4][5]. Major reasons for the current success of bioluminescence imaging (BLI) include: the great detectability (signal to noise) due to essentially nonexistent endogenous background; wide dynamic range; and the availability of reasonably priced commercial CCD-based detection devices [1][2][3]. Moreover, a particular advantage of the beetle Lucs, which produce light by oxidizing the luciferin substrate (LH 2 ) in reactions that also require Mg-ATP and molecular * To whom correspondence should be addressed: Tel.: + 1 860 439-2479, brbra@conncoll.edu. 1 Abbreviations used: BLI, bioluminescence imaging; CBR, Promega's click beetle red, recombinant Pyrophorus plagiophthalamus luciferase (GenBank: AY258591); LH 2 , D-firefly luciferin; Luc, luciferase; Luc2, Promega's Photinus pyralis-based luciferase (GenBank: AY738222); PLG2, recombinant P. pyralis luciferase variant (GenBank: KY486507); PLR3, recombinant P. pyralis luciferase variant (GenBank: KY486508); PpyRE9, recombinant P. pyralis luciferase variant (GenBank: GQ404466); and RLU, relative light units. All luciferases were expressed from the human codon optimized sequences indicated above. Competing interests statementThe authors declare no competing interests. Mainly for reasons of improved detectability that can be achieved by the more efficient transmission of light through animal tissues, light emission at wavelengths greater than 600 nm is highly advantageous [7,8] for good expression and stability at 37 °C, the specific activity was ~3.5-fold lower and the emission maxima was slightly blue-shifted (Table 1). Importantly, we succeeded in reducing both K m values: ~30-fold for Mg-ATP (3-fold greater than that for CBR) and ~7-fold for LH 2 (~2-fold lower than the CBR value). The mutations primarily responsible for the redshifted emission were Y255F and S284T, while the lowered K m values resulted from the G246A, F250H, and V351I amino acid changes that also contributed to the relative drop in...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.